BioFluidica
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11575 Sorrento Valley Rd Ste 210, San Di...Phone Number
(858) 535-6493Website
www.biofluidica.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About BioFluidica
BioFluidica is a privately held biotechnology company that has developed a revolutionary platform enabling disease management and diagnosis through prognosis, all from a simple blood test. The BioFluidica microfluidic platform can capture and isolate disease biomarkers, such as Circulating Tumor Cells (CTC), and has been clinically validated. Its ability to scan whole blood for the first signs of a disease, finding the rarest biomarkers with unmatched sensitivity, means fulfilling the promise of a true liquid biopsy. BioFluidica is revolutionizing disease detection by bringing better samples to millions of people.Explore more
BioFluidica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioFluidica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if BioFluidica is spiking on competitors!
Earning: See what the market has to say on BioFluidica recently announced quarterly report
Product Launch: Get notified when BioFluidica launches new products
Funding: Get notified immidiatlly once BioFluidica has new funding data
Congratulate Masked Content for being promoted to Masked Content at BioFluidica
Check if BioFluidica has recently received funding, and reach out quickly before it becomes old news!
Click to see if BioFluidica had a recent Job posting/layoffs
BioFluidica, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to BioFluidica
Compare insights from companies similar to BioFluidica, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioFluidica is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioFluidica is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioFluidica.
BioFluidica financials insights
Gather financial insights about BioFluidica, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$2M
2017
Private Equity
$4.1M
2020
Debt
$150K
2021
Debt
$208K
2022
Series B
$6M
BioFluidica Tech Stack
A closer look at the technologies used by BioFluidica
Most Recent Scoops
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
New Hire
Executive Move
Stephen Sharp has joined the organization as Director, Marketing & Product Management.
Executive Moves, New Hire
Funding
Funding
BioFluidica has received an SBA PPP loan in the amount of $208,988 from Silicon Valley Bank resulting in the retention of 9 jobs.
Funding
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding BioFluidica
Sign Up For FreeTo access detailed company insights
BioFluidica is a privately held biotechnology company that has developed a revolutionary platform enabling disease management and diagnosis through prognosis, all from a simple blood test. The BioFluidica microfluidic platform can capture and isolate disease biomarkers, such as Circulating Tumor Cells (CTC), and has been clinically validated. Its a... Read More
